The athenahealth, Inc. (ATHN) Given a $110.00 Price Target by Leerink Swann Analysts, Report finds

ATHN has been the subject of a number of other reports. Jefferies Group LLC increased their target price on shares of athenahealth from $105.00 to $110.00 and gave the company an underperform rating in a research report on Friday, October 14th. Canaccord Genuity reiterated a hold rating and issued a $112.00 target price on shares of athenahealth in a research report on Monday, February 6th. J P Morgan Chase & Co cut shares of athenahealth from an overweight rating to a neutral rating and reduced their target price for the company from $128.00 to $111.00 in a research report on Friday, October 28th. Evercore ISI upgraded shares of athenahealth from a hold rating to a buy rating and set a $152.00 target price for the company in a research report on Monday, October 10th. Finally, Dougherty & Co started coverage on shares of athenahealth in a research report on Friday, December 2nd. They issued a buy rating and a $130.00 target price for the company. Two analysts have rated the stock with a sell rating, eight have assigned a hold rating and eleven have assigned a buy rating to the company’s stock. The company presently has a consensus rating of Hold and a consensus target price of $132.79.

Leerink Swann set a $110.00 price target on athenahealth, Inc. (NASDAQ:ATHN) in a report released on Tuesday. The firm currently has a hold rating on the stock.

Shares of athenahealth (NASDAQ:ATHN) opened at 113.88 on Tuesday. The company’s 50-day moving average is $116.99 and its 200-day moving average is $115.49. athenahealth has a one year low of $90.11 and a one year high of $143.85. The company has a market cap of $4.50 billion, a price-to-earnings ratio of 219.00 and a beta of 1.77.

athenahealth (NASDAQ:ATHN) last issued its earnings results on Thursday, February 2nd. The company reported $0.62 EPS for the quarter, beating the Zacks’ consensus estimate of $0.51 by $0.11. The business earned $288.20 million during the quarter, compared to analysts’ expectations of $303.72 million. athenahealth had a net margin of 1.94% and a return on equity of 6.41%. The company’s quarterly revenue was up 11.9% compared to the same quarter last year. During the same period in the prior year, the business earned $0.45 earnings per share. On average, equities analysts predict that athenahealth will post $2.47 EPS for the current year.

In related news, Director Amy Abernethy sold 1,000 shares of the firm’s stock in a transaction that occurred on Thursday, December 15th. The shares were sold at an average price of $117.15, for a total value of $117,150.00. Following the sale, the director now owns 2,649 shares of the company’s stock, valued at $310,330.35. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, COO Ed Park sold 2,500 shares of the firm’s stock in a transaction that occurred on Thursday, December 15th. The shares were sold at an average price of $117.15, for a total transaction of $292,875.00. Following the completion of the sale, the chief operating officer now directly owns 13,219 shares in the company, valued at approximately $1,548,605.85. The disclosure for this sale can be found here. Insiders have sold 19,875 shares of company stock worth $2,345,866 in the last three months. Corporate insiders own 3.04% of the company’s stock.

Hedge funds have recently modified their holdings of the stock. Sumitomo Mitsui Asset Management Company LTD purchased a new stake in shares of athenahealth during the third quarter valued at $24,101,000. Morgan Stanley boosted its stake in shares of athenahealth by 3.1% in the third quarter. Morgan Stanley now owns 3,582,728 shares of the company’s stock valued at $451,854,000 after buying an additional 108,646 shares during the period. Riverbridge Partners LLC boosted its stake in shares of athenahealth by 9.4% in the third quarter. Riverbridge Partners LLC now owns 1,072,483 shares of the company’s stock valued at $135,261,000 after buying an additional 92,178 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank boosted its stake in shares of athenahealth by 2,363.8% in the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 33,015 shares of the company’s stock valued at $4,164,000 after buying an additional 31,675 shares during the period. Finally, Stephens Investment Management Group LLC boosted its stake in shares of athenahealth by 12.5% in the third quarter. Stephens Investment Management Group LLC now owns 268,162 shares of the company’s stock valued at $33,821,000 after buying an additional 29,743 shares during the period.

About athenahealth

athenahealth, Inc is a provider of cloud-based services and mobile applications for medical groups and health systems. The Company delivers cloud-based services for revenue cycle management and medical billing, electronic health records (EHR), patient engagement, care coordination, order transmission, population health management, and clinical decision support.

Leave a Reply

Your email address will not be published. Required fields are marked *